C16 Biosciences
Next-gen ingredients to decarbonize consumer products, starting w/…
C16 Biosciences is decarbonizing consumer products supply chains by producing next-generation ingredients. The company's biomanufacturing platform produces better performing, more sustainable alternatives to oils and fats, and their first product is an alternative to palm oil. The company owns and operates Palmless™ alternative fats and oils.
- Website
- c16bio.com
- City
- New York City
- Country
- United States
- YC batch
- Summer 2018
- Team
- 35 people
- Stage
- Growth stage
- AI-native
- No
More Health & bio in New York City
Ro$5bn
Health technology. Valued at $5bn (March 2021).
Noom$3.7bn
Healthcare. Valued at $3.7bn (May 2021).
Headway$2.3bn
Healthcare. Valued at $2.3bn (July 2024).
Sword Health$2bn
Health. Valued at $2bn (November 2021).
H1
Connecting stakeholders across the healthcare ecosystem.
Opentrons
We make robots for biologists.
Claim this profile
Free and instant: prove you run c16bio.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to C16 Biosciences across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with C16 Biosciences's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
